Segmentation by type classifies Medical Air Disinfection Machines into UV‑C irradiation, HEPA‑based filtration, photocatalytic oxidation (PCO), chemical vapor systems, and hybrid configurations that combine two or more mechanisms. UV‑C units, responsible for roughly 40 % of the market, leverage germicidal wavelengths to achieve >99.9 % pathogen inactivation and are favored in large‑scale hospital ducts where continuous flow is essential. HEPA‑based devices, capturing particles down to 0.3 µm, account for about 25 % and are prevalent in operating rooms and isolation wards where particulate removal complements microbial kill. PCO systems, comprising roughly 15 % of sales, employ titanium‑dioxide catalysts activated by UV light to oxidise organic contaminants, offering a chemical‑free alternative for clinics with limited space. Chemical vapor generators, representing 10 % of the market, release controlled doses of agents such as hydrogen peroxide for terminal disinfection of closed environments. The remaining 10 % consists of hybrid solutions that integrate UV‑C and HEPA or PCO, providing layered protection and driving incremental value in high‑risk settings. Each type’s cost structure, maintenance cycle, and efficacy profile shape its contribution to total market revenue.